Researchers recently evaluated how different congenital malformation algorithms influence prevalence estimates within large mother-child cohorts. Major congenital malformations (MCM) affect approximately 2% to 6% of pregnancies worldwide. However, identifying these cases using real-world data is often difficult because definitions and case ascertainment criteria vary significantly across different healthcare systems. This inconsistency can limit international collaborations and skew research findings in pharmacoepidemiology.

A comparative study utilized data from the Québec Pregnancy Cohort (QPC), analyzing 233,338 infants from singleton pregnancies. The researchers tested ten distinct algorithms to determine their effectiveness in identifying MCMs. These methods varied based on data sources, such as inpatient versus outpatient records, and the specific time windows for detection, ranging from 28 days to one year. The study excluded infants with isolated chromosomal malformations or those born at a gestational age of 20 weeks or less.

Optimizing Accuracy with Congenital Malformation Algorithms

The results revealed that global MCM prevalence fluctuated dramatically between 2.9% and 9.0% depending on the chosen criteria. Musculoskeletal and circulatory anomalies remained the most prevalent across all algorithms. Furthermore, using a single diagnostic code within the first year of life frequently led to an overestimation of prevalence rates. Consequently, researchers found that more stringent criteria were necessary to align data with expected international benchmarks.

Specifically, an algorithm requiring at least one inpatient code or two outpatient codes for the same organ system on different days yielded a prevalence of 5.0%. This figure closely matches international expectations and appears well-suited for cohorts where inpatient diagnostic codes are highly reliable. Moreover, transparent definitions are essential for enhancing the reproducibility of studies. Therefore, selecting the correct congenital malformation algorithms is a critical step for clinicians and researchers attempting to generate accurate public health data.

Frequently Asked Questions

Why does the choice of algorithm matter in congenital malformation research?

Algorithm choice matters because different definitions can lead to vastly different prevalence estimates, ranging from 2.9% to 9.0%. Standardizing these definitions ensures that data is comparable across different studies and geographic regions.

Which coding criteria provide the most reliable prevalence estimates?

The most reliable estimates often come from algorithms that require either one inpatient diagnostic code or at least two outpatient codes for the same organ system. This approach reduces the risk of overestimation associated with single outpatient entries.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any medical concerns. Refer to the latest local and national guidelines for clinical practice.

References

Nohmie G et al. Impact of Major Congenital Malformation Algorithms on Their Prevalence in Large Population-Based Mother-Child Cohorts. Paediatr Perinat Epidemiol. 2026 Mar 16. doi: 10.1111/ppe.70129. PMID: 41839736.

Jacobson MH, et al. Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review. Drug Saf. 2025 Sep 13. doi: 10.1007/s40264-025-01606-w.

Bhardwaj M, et al. Prevalence of Congenital Malformations in India: A Systematic Review. Indian Journal of Pediatrics. 2023.